ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
2,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
2,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
3,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
3,2,Headache,Headaches NEC,Headaches,Nerv,N
3,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
3,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
3,5,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
3,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
3,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
3,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
3,11,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
3,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
4,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
5,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
6,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
6,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
6,4,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
7,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
7,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
7,4,Tension headache,Headaches NEC,Headaches,Nerv,N
8,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
9,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
9,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
9,5,Injection site dermatitis,Injection site reactions,Administration site reactions,Genrl,N
9,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
9,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
11,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
11,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
11,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
12,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
12,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
13,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
13,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
14,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
14,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
15,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
15,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
15,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
16,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
16,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
17,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
18,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
19,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
19,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
19,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
19,6,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
20,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
21,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
21,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
21,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
22,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
23,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
23,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
23,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
23,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
24,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
24,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
25,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
25,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
25,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
25,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
25,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
26,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
27,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
27,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
27,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
27,5,Headache,Headaches NEC,Headaches,Nerv,N
27,6,Neoplasm skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
27,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
27,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
28,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
29,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
29,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
29,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
30,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
30,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
30,3,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
30,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
30,5,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
30,6,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
31,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
31,2,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
31,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
31,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
31,5,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
31,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
31,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
33,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
33,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
33,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
33,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
33,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
33,7,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
34,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
35,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
36,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
36,2,Thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
37,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
38,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
38,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
38,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
38,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
39,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
39,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
40,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
40,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
41,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
42,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
42,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
44,2,Headache,Headaches NEC,Headaches,Nerv,N
45,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
46,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
47,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
47,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
47,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
48,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
49,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
50,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
51,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
52,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
52,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
53,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
53,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,4,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
53,6,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
54,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
54,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
54,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
55,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
56,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
56,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
57,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
57,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
57,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
57,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
58,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
59,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
59,2,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
60,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
60,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
60,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,4,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
60,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
61,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
61,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
62,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
63,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
63,2,Inguinal hernia,Inguinal hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
64,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
65,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
66,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
66,2,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
66,3,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
66,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
66,5,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
66,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
67,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
67,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
67,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
67,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Headache,Headaches NEC,Headaches,Nerv,N
68,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
68,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
68,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
69,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,3,Headache,Headaches NEC,Headaches,Nerv,N
69,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,5,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
69,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,7,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
69,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,1,Abnormal faeces,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
70,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
70,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
70,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
70,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
70,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
70,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
70,9,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
70,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
70,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
71,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
71,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
72,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
72,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
73,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
74,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
75,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
76,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
76,2,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
77,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
78,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
79,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
79,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
79,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
79,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
79,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
81,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
82,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
82,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
84,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
84,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
84,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
85,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
86,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
86,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
86,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
86,4,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
86,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
87,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
88,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
88,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
89,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
90,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
91,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
92,1,Urticaria chronic,Urticarias,Angioedema and urticaria,Skin,N
93,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
93,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
93,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
94,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
94,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
94,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
95,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
95,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
96,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
96,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
96,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
96,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
97,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
98,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
98,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
98,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
98,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
99,1,Cerebral venous thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
100,1,Papillary thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
101,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
102,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
102,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
103,1,Pulmonary sarcoidosis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
104,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
104,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
104,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
104,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
104,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
104,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
104,7,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
104,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
105,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
105,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
106,1,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
107,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
108,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
109,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
109,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
109,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
109,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
109,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
110,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
110,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
110,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
110,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
110,6,Headache,Headaches NEC,Headaches,Nerv,N
110,7,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
110,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
110,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
110,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
111,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
111,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
112,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
113,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
113,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
113,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
113,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
113,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
114,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
114,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
115,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
115,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
115,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
115,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
115,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
116,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
116,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
117,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
117,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
117,3,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
117,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
117,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
117,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
118,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
118,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
119,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
120,1,Headache,Headaches NEC,Headaches,Nerv,N
120,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
120,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
120,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
121,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
122,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
122,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
122,3,Headache,Headaches NEC,Headaches,Nerv,N
122,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
122,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
122,6,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
122,7,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
123,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
124,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
124,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
124,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
124,4,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
124,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
125,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
126,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
126,3,Sensation of blood flow,Feelings and sensations NEC,General system disorders NEC,Genrl,N
126,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
126,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
127,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
127,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
127,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
127,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
128,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
129,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
129,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
129,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
129,4,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
130,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
130,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
131,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
133,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
133,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
133,3,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
133,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
133,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
133,6,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
133,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
133,8,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
133,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
133,10,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
133,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,12,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
134,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
135,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
135,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
135,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
136,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
137,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
137,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
137,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
137,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
137,5,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
138,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
138,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
138,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
138,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
138,5,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
138,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
138,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
138,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
139,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
140,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
140,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
141,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
142,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
142,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
143,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
143,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
143,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
143,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
143,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
143,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
143,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
144,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
145,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
146,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
146,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
146,3,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
146,4,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
146,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
146,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
147,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
147,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
147,3,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
148,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
148,2,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
149,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
150,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
150,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
150,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
150,4,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
151,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
151,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
151,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
151,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
151,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
151,6,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
151,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
151,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
151,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
152,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
153,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
154,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
154,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
155,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
156,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
157,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
157,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
157,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
157,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
157,5,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
157,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
157,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
157,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
158,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
159,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
160,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
160,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
160,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
161,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
162,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
162,2,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
162,3,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
162,4,Polymenorrhoea,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
163,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
164,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
164,2,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
164,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
165,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
165,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
166,1,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
167,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
167,2,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
167,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
167,4,Oesophageal oedema,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
167,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
168,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
168,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
169,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
170,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
170,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
170,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
170,4,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
170,5,Injection site ulcer,Injection site reactions,Administration site reactions,Genrl,N
171,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
171,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
171,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
171,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
172,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
173,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
174,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
174,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
174,3,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
174,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
175,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
175,2,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
176,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
176,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
176,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
176,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
176,6,Myalgia,Muscle pains,Muscle disorders,Musc,N
176,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
176,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
176,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
177,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
178,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
178,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
178,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
178,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,5,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
179,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
179,2,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
179,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
179,4,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
179,5,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
179,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
179,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
179,8,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
179,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
180,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
181,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
182,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
182,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
183,1,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
184,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
185,1,Acute promyelocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
186,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
186,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
186,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
187,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
187,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
187,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
187,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
187,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,6,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
188,1,Premature menopause,Menopausal effects NEC,Menopause related conditions,Repro,N
189,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
190,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
190,2,Headache,Headaches NEC,Headaches,Nerv,N
190,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
190,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
190,5,Rectal tenesmus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
190,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
191,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
191,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
191,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
192,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
192,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
192,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
192,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
192,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
193,1,Ectopic pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
194,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
195,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
196,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
196,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
196,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
196,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
196,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
196,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
196,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
197,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
197,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
197,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
197,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
197,6,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
197,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
197,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
198,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
198,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
198,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
199,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
199,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
199,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
199,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
199,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
199,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
200,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,5,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
200,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
200,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
200,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
200,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
200,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
202,1,Breast cancer stage III,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
202,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
202,3,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
202,4,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
203,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
204,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
205,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
205,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
205,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
205,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
205,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
205,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
205,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
206,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
206,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
206,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
206,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
207,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
207,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
208,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
208,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
208,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
208,4,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
208,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
208,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
209,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
209,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
209,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
209,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
209,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
209,6,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
209,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
209,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
210,2,Headache,Headaches NEC,Headaches,Nerv,N
210,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
210,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
210,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
210,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
211,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
211,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
211,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
211,4,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
211,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
211,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
212,1,Application site bruise,Application site reactions,Administration site reactions,Genrl,N
212,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
212,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
212,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
212,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
212,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
212,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
213,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
214,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
215,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
215,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
215,3,Injection site fibrosis,Injection site reactions,Administration site reactions,Genrl,N
215,4,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
215,5,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
215,6,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
215,7,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
215,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
216,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
216,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
217,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
218,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
219,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
219,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
220,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
221,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
221,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
221,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
221,4,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
221,5,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
223,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
224,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
224,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
224,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
224,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
224,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
224,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
225,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
226,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
226,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
226,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
227,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
227,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
227,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
227,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
227,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
227,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,7,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
227,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
227,9,Headache,Headaches NEC,Headaches,Nerv,N
227,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
227,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
227,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
227,14,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
227,15,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
227,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
228,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
229,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
229,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
229,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
230,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
230,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
230,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
230,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
231,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
231,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
231,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
231,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
231,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
231,6,Lip disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
231,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
231,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
232,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
232,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
233,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
234,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
234,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
235,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,2,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
235,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
235,5,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
236,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
236,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
236,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
236,4,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
236,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
237,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
237,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
238,1,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
238,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
239,1,Sarcoma,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
240,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
241,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
242,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
242,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
242,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
243,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
244,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
245,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
245,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
245,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,4,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
245,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
245,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
246,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
246,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
246,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
246,4,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
246,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
247,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
247,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
247,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
247,4,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
248,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
248,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
248,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
248,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
248,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
248,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
248,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
248,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
249,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
249,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
250,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
250,2,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
251,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
252,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
252,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
252,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
252,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
252,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
253,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
253,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
253,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
253,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
254,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
254,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
254,3,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,4,Mouth swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
254,5,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
254,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
255,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
256,1,Selective eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
257,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
258,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
259,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
259,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
260,1,Abortion missed,Abortions not specified as induced or spontaneous,Abortions and stillbirth,Preg,N
261,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
261,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
261,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
261,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
262,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
262,2,Injection site oedema,Injection site reactions,Administration site reactions,Genrl,N
262,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
262,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
262,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
262,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
263,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
263,2,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
264,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
264,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
264,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
264,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
264,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
264,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
264,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
265,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
265,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
265,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
266,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
267,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
268,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
268,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
268,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
268,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
268,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
268,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
268,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
268,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
268,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
268,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
268,12,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
269,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
269,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
270,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
271,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
271,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
271,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
271,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
271,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
271,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,7,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,8,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,9,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
271,10,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
271,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
271,12,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
271,13,Respiratory arrest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
271,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
272,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
272,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
272,3,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
272,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
273,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
273,2,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
273,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
273,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
274,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
274,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
275,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
275,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
275,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
275,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
276,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
277,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
277,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
278,1,Arterial thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
278,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
278,3,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
279,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
280,1,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
280,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
280,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
280,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
281,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
282,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
282,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
282,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
282,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
283,1,Headache,Headaches NEC,Headaches,Nerv,N
283,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
283,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
283,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
283,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
284,1,Administration site reaction,Administration site reactions NEC,Administration site reactions,Genrl,N
284,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
285,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
285,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
285,4,Headache,Headaches NEC,Headaches,Nerv,N
286,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
286,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
286,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
287,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
287,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
288,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
288,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
288,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
288,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
288,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
288,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
288,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
288,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
288,9,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
288,10,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
288,12,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
288,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
289,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
290,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
290,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
290,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
290,5,Headache,Headaches NEC,Headaches,Nerv,N
290,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
290,7,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
290,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
290,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
291,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
291,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
291,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
291,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
291,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
292,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
292,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
292,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
292,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
292,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
292,8,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
292,9,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
292,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
292,11,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
292,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
292,13,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
292,14,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
293,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
294,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
294,2,Headache,Headaches NEC,Headaches,Nerv,N
294,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
294,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
295,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
295,3,Headache,Headaches NEC,Headaches,Nerv,N
295,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
295,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,6,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
296,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
297,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
297,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
297,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
297,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
297,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
297,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
297,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
297,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
297,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
298,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
298,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
298,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
298,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
298,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
298,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
298,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
298,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
299,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
299,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
299,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
299,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
299,6,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
299,7,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
299,8,Headache,Headaches NEC,Headaches,Nerv,N
299,9,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
299,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
299,11,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
299,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
299,14,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
299,15,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
299,16,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
299,17,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
300,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
301,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
302,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
302,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
302,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
303,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
303,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
304,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
305,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
305,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
305,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
305,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
305,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
306,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
306,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
306,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
306,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
306,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
306,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
307,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
307,3,Headache,Headaches NEC,Headaches,Nerv,N
307,4,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
308,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
308,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
309,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
309,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
309,3,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
309,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
309,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
309,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
310,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
311,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
311,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
311,3,Ear pruritus,Ear disorders NEC,Aural disorders NEC,Ear,N
311,4,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
311,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
311,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
311,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
311,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
311,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
311,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
311,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
311,12,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
311,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
311,14,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,15,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
311,16,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
311,17,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
311,18,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
311,19,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
311,20,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
312,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
312,2,Iron deficiency,Iron deficiencies,Iron and trace metal metabolism disorders,Metab,N
312,3,Peripheral artery thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
312,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
313,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
313,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
313,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
313,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
314,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
314,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
314,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
314,5,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
315,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
315,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
315,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
315,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
315,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
315,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
316,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
317,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
317,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
318,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
318,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
318,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
318,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
318,5,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
319,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
319,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
319,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
320,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
321,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
321,2,Headache,Headaches NEC,Headaches,Nerv,N
321,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
321,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
321,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
321,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
322,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
322,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
322,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
322,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
322,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
322,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
322,7,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
322,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
322,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
323,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
324,1,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
324,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
324,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
324,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
324,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
324,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
324,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
325,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
325,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
325,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
326,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
326,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
327,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
327,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
327,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
327,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
328,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
328,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
328,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
329,1,Adenocarcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
330,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
331,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
331,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
332,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
333,1,Adhesion,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
335,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
335,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
335,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
335,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
335,5,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
336,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
337,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
337,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
337,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
337,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
337,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
337,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
338,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
338,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
338,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
338,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
338,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
339,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
340,1,Chronic lymphocytic leukaemia,Leukaemias chronic lymphocytic,Leukaemias,Neopl,N
341,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
342,1,Cervix carcinoma,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
343,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
343,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
343,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
344,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
344,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
344,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
345,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
345,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
345,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
345,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
346,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
346,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
346,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
346,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
346,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
346,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
346,10,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
347,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
347,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
347,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
347,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
347,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
347,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
347,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
347,8,Headache,Headaches NEC,Headaches,Nerv,N
347,9,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
347,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
347,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
347,12,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,13,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
347,14,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
347,15,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
347,16,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
349,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
350,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
351,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
351,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
352,1,Idiopathic urticaria,Urticarias,Angioedema and urticaria,Skin,N
353,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
354,1,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
355,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
355,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
355,4,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
355,5,Headache,Headaches NEC,Headaches,Nerv,N
355,6,Headache,Headaches NEC,Headaches,Nerv,N
355,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
355,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
355,9,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
355,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
355,11,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
355,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
355,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
355,14,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
355,15,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
356,1,Endometrial stromal sarcoma,Endometrial neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
356,2,Laparotomy,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
357,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
357,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
357,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
357,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
357,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
357,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
358,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
358,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
358,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
358,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
358,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
359,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
359,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
359,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
359,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
360,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
360,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
360,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
360,4,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
360,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
360,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
360,7,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
361,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
362,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
362,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
362,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
362,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
363,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
363,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
363,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
364,2,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
364,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
364,4,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
364,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
364,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
364,7,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
364,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
364,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
365,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
366,1,Bladder dysfunction,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
366,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
366,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
366,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
366,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
367,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
367,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
367,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
367,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
367,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
367,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
367,7,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
367,8,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
367,9,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
367,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
368,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
368,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
368,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
368,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
368,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
368,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
368,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
368,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
369,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
369,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
369,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
369,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
369,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,7,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
369,8,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
369,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
370,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
371,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
371,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
371,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
371,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
372,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
373,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
374,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
374,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
374,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
374,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
374,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
374,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
375,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
376,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
376,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
376,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
377,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
378,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
378,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
378,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
378,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
378,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
378,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
378,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
378,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
379,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
380,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
380,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
380,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
381,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
381,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
381,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
381,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
382,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
382,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
382,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
382,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
382,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
382,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
382,7,Physical disability,Disability issues,Lifestyle issues,SocCi,N
383,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
383,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
383,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
383,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
383,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
383,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
383,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
383,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
383,11,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
384,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
384,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
384,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
384,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
385,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
385,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
385,3,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
385,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
385,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
385,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
385,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
385,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
386,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
386,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
386,3,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
387,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
387,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
387,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
388,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
389,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
390,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
391,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
392,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
393,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
394,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
395,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
396,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
397,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
398,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
399,1,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
399,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
399,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
399,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
399,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
399,6,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
399,7,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
400,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
401,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
401,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
402,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
403,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
404,1,Headache,Headaches NEC,Headaches,Nerv,N
404,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
404,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
404,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
405,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
405,3,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
405,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
405,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
405,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
405,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
405,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
405,9,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
406,1,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
406,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
407,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
407,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
407,3,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,5,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
407,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
408,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
408,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
409,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
409,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
409,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
409,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
409,10,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
410,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
411,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
411,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
411,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
412,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
412,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
412,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
412,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
412,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
413,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
413,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
414,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
414,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
414,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
414,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
414,5,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
415,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
416,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
416,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
417,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
417,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
418,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
418,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
418,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
419,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
419,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
419,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
419,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
419,5,Headache,Headaches NEC,Headaches,Nerv,N
419,6,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
419,7,Tension,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
419,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
420,1,Foetal heart rate decreased,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
420,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
420,3,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
420,4,Ultrasound abdomen abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
420,5,Ultrasound antenatal screen abnormal,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
420,6,Ultrasound antenatal screen abnormal,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
421,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
421,2,Cutaneous sarcoidosis,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
421,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
421,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
421,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
421,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
421,7,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
421,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
421,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
421,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
421,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
423,1,Breast mass,Breast disorders NEC,Breast disorders,Repro,N
424,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
424,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
424,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
424,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
424,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
424,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
424,7,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
424,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
424,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
424,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
424,11,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
424,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
425,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
426,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
426,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
427,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
427,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
427,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
427,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
428,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
428,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
428,3,Femoral neck fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
428,4,Ingrowing nail,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
428,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
428,6,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
429,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
429,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
429,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
429,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
429,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
430,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
430,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
430,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
431,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
431,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
432,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
432,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
432,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
432,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
432,5,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
432,6,Headache,Headaches NEC,Headaches,Nerv,N
432,7,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
432,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
432,9,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
432,10,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
432,11,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
432,12,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
433,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
433,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
433,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
433,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
434,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
435,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
436,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
436,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
436,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
437,1,Testis cancer,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
438,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
439,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
440,1,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
440,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
440,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
440,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
440,5,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
441,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
441,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
441,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
441,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
441,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
441,6,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
441,7,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
442,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
442,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
442,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
442,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
442,5,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
442,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
442,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
442,8,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
442,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
442,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
442,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
442,12,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
442,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
443,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
444,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
444,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
444,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
445,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
446,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
447,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
447,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
447,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
447,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
447,6,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
447,7,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
448,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
448,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
449,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
449,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
449,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
449,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
449,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
449,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
449,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
449,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
450,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
450,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
450,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
450,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
450,5,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
450,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
450,7,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
450,8,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
450,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
450,10,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
450,11,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
450,12,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
450,13,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
450,14,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
450,15,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
450,16,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
451,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
451,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
451,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
451,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
451,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
452,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
453,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
453,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
454,1,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
454,2,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
455,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
455,2,Pharyngeal erythema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
455,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
455,5,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
455,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
456,1,Multiple injuries,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
456,2,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
457,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
457,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
457,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
457,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
457,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
457,6,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
457,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
457,8,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
457,9,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
457,10,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
457,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
457,12,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
458,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
458,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
459,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
459,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
459,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
459,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
459,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
460,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
460,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
460,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
460,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
460,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
460,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
460,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
461,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
461,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
461,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
461,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
462,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
463,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
463,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
463,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
463,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
463,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
463,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
463,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
463,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
464,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
464,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
464,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
465,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
465,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
465,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
466,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
467,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
467,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
467,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
467,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
468,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
468,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
469,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
469,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
470,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
470,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
470,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
470,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
470,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
470,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
470,7,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
470,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
471,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
471,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
471,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
471,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
471,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
471,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
471,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
472,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
472,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
472,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
472,4,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
472,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
472,6,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
472,7,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
472,8,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
473,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
473,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
473,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
474,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
474,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
474,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
475,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
475,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
475,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
475,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
476,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
476,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
476,3,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
477,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
478,1,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
478,2,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
479,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
479,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
479,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
479,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
480,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
480,2,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
480,3,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
480,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
481,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
481,4,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
481,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
481,6,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
481,7,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
481,8,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
481,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
481,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
481,11,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
481,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
481,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,14,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
481,15,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
482,1,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
482,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
482,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
482,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
482,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
483,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
484,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
484,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
484,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
484,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
484,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
485,1,Headache,Headaches NEC,Headaches,Nerv,N
485,2,Impaired driving ability,Disability issues,Lifestyle issues,SocCi,N
485,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
486,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
486,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
486,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
486,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
487,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
487,2,Anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
487,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
487,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
488,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
489,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
489,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
490,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
490,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
490,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
490,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
490,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
490,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
490,7,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
490,8,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
490,9,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
491,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
491,2,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
492,1,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
492,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
492,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
493,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
493,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
494,1,Addison's disease,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
494,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
494,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
495,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
495,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
495,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
496,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
496,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
497,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
497,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
497,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
497,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
497,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
497,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
498,1,Benign neoplasm of thyroid gland,Thyroid neoplasms benign,Endocrine neoplasms benign,Neopl,N
498,2,Thyroid adenoma,Thyroid neoplasms benign,Endocrine neoplasms benign,Neopl,N
499,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
499,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
499,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
499,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
499,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
499,6,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
499,7,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
499,8,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
499,9,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
499,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
499,11,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
499,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
499,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
499,14,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
499,15,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
500,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
501,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
501,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
501,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
501,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
501,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
501,6,Exercise tolerance decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
501,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
501,9,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
501,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
501,11,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
502,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
503,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
503,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
503,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
503,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
503,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
503,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
503,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
503,8,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
504,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
504,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
504,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
504,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
504,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
505,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
505,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
506,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
506,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
506,5,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
506,6,Eye movement disorder,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
506,7,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
506,8,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
506,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
506,10,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
506,11,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
506,12,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
507,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
507,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
508,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
509,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
509,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
509,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
509,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
509,5,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
509,6,Tongue injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
510,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
510,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
510,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
510,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
510,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
511,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
511,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
511,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
512,1,Delusion of parasitosis,Delusional symptoms,Disturbances in thinking and perception,Psych,N
513,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
514,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
514,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
515,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
515,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
515,3,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
515,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
515,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
516,1,Muscle necrosis,Myopathies,Muscle disorders,Musc,N
516,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
517,1,Granuloma annulare,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
517,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
517,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
518,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
519,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
519,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
520,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
520,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
520,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
520,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
520,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
521,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
521,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
521,3,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
521,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
522,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
522,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
523,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
523,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
523,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
524,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
524,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
524,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
525,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
525,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
525,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
526,1,Smear site unspecified abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
527,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
528,1,Benign neoplasm of thyroid gland,Thyroid neoplasms benign,Endocrine neoplasms benign,Neopl,N
529,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
529,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
529,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
529,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
529,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
530,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
531,1,Corneal thinning,"Corneal structural change, deposit and degeneration","Anterior eye structural change, deposit and degeneration",Eye,N
531,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
531,3,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
532,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
532,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
532,3,Ear discomfort,Ear disorders NEC,Aural disorders NEC,Ear,N
532,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
534,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
534,2,Fat intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
534,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
534,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
534,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
534,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
534,7,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
534,8,Myalgia,Muscle pains,Muscle disorders,Musc,N
534,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
534,10,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
534,11,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
534,12,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
535,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
535,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
536,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
536,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
537,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
537,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
538,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
539,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
539,2,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
539,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
539,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
539,5,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
539,6,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
540,1,Disability,Disability issues,Lifestyle issues,SocCi,N
540,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
540,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
541,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
542,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
542,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
542,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
543,2,Dyslipidaemia,Lipid metabolism and deposit disorders NEC,Lipid metabolism disorders,Metab,N
544,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
544,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
544,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
544,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
544,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
544,6,Therapeutic product ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
546,1,Carbohydrate antigen 125 increased,Cell marker analyses,Cytogenetic investigations and genetic analyses,Inv,N
546,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
547,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
547,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
547,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
547,4,Suffocation feeling,Respiratory signs and symptoms NEC,Respiratory tract signs and symptoms,Resp,N
547,5,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
548,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
548,2,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
549,1,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
550,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
550,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
550,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
551,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
551,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
551,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
551,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
551,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
551,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
551,7,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
551,8,Relapsing-remitting multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
551,9,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
551,10,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
552,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
552,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
552,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,5,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
552,6,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
552,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
552,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
552,9,Piloerection,Pilar disorders NEC,Skin appendage conditions,Skin,N
552,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
552,11,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
553,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
553,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
553,3,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
553,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
553,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
553,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
554,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
554,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
554,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
554,4,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
554,5,Injection site thrombosis,Injection site reactions,Administration site reactions,Genrl,N
555,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
555,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
556,1,Cervix haemorrhage uterine,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
557,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
557,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
557,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
558,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
559,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
559,2,Optic neuritis,Optic nerve disorders NEC,Cranial nerve disorders (excl neoplasms),Nerv,N
560,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
560,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
560,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
560,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
560,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
561,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
561,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
561,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
561,4,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
561,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
561,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
561,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
561,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
561,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
561,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
561,11,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
561,12,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
561,13,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
561,14,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
561,15,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
561,16,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
561,17,Pelvic pain,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
561,18,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
561,19,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
562,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
562,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
562,3,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
563,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
563,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
563,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
564,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
565,1,Pancreatic neoplasm,Gastrointestinal neoplasms malignancy unspecified NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
566,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
567,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
567,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
567,3,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
567,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
567,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
567,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
567,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
568,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
568,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
568,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
568,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
568,5,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
569,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
569,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
569,3,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
569,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
569,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
569,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
569,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
569,9,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
570,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
570,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
570,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
571,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
571,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
571,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
571,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
571,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
571,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
571,7,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
571,8,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
571,9,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
571,10,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
571,11,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
571,12,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
571,13,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
572,1,Colon cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
572,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
572,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
572,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
573,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
574,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
574,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
575,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
575,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
576,1,Adenocarcinoma of the cervix,Cervix neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
576,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
577,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
577,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
577,3,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
577,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
577,5,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
578,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
579,1,Fibroma,Neoplasms benign site unspecified NEC,Miscellaneous and site unspecified neoplasms benign,Neopl,N
579,2,Splenectomy,Lymphoid tissue therapeutic procedures,Haematological and lymphoid tissue therapeutic procedures,Surg,N
580,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
580,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
581,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
581,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
581,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
582,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
582,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
583,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
583,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
583,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
583,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
583,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
583,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
583,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
584,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
585,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
586,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
586,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
586,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
586,4,Inability to crawl,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
586,5,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
586,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
586,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
586,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
587,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
587,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
588,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
588,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
588,3,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
588,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
588,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
589,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
590,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
591,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
591,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
591,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
591,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
591,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
591,6,Headache,Headaches NEC,Headaches,Nerv,N
591,7,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
591,8,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
591,9,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
591,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
591,11,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
592,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
592,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
592,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
592,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
593,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
593,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
593,3,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
593,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
593,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
594,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
595,1,Radical cystectomy,Bladder therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
596,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
597,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
598,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
599,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
600,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
600,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
600,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
600,4,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
600,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
600,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
600,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
601,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
601,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
601,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
601,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
601,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
601,6,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
601,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
601,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
602,1,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
602,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
602,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
602,4,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
602,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
602,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
602,7,Headache,Headaches NEC,Headaches,Nerv,N
602,8,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
602,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
602,10,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
602,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
603,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
603,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
603,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
603,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
603,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
603,6,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
603,7,Indifference,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
603,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
603,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
603,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
604,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
604,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
604,3,Panniculitis,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
605,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
605,2,Lactation disorder,Lactation disorders,Breast disorders,Repro,N
605,3,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
605,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
606,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
606,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
607,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
608,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
608,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
608,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
609,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
609,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
609,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
609,5,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
609,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
609,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
609,8,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
609,9,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
609,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
609,11,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
609,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
609,13,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
610,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
611,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
611,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
612,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
613,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
613,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
613,3,Injection site plaque,Injection site reactions,Administration site reactions,Genrl,N
613,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
613,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
613,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
614,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
614,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
615,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
616,1,Malignant melanoma stage III,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
617,1,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
618,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
618,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
618,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
619,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
619,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
620,1,Disability,Disability issues,Lifestyle issues,SocCi,N
620,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
620,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
621,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
621,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
622,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
622,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
622,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
622,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
623,1,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
623,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
623,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
624,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
624,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
624,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
625,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
626,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
626,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
626,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
626,4,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
626,5,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
627,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
627,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
627,3,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
627,4,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
628,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
628,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
628,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
628,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
628,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
628,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
628,7,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
629,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
630,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
630,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
630,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
631,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
632,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
632,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
632,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
632,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
632,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
632,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
632,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
632,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
632,9,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
632,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
633,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
633,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
633,3,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
634,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
634,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
634,3,Lack of injection site rotation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
634,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
635,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
635,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
635,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
635,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
635,5,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
635,6,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
636,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
636,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
636,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
637,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
637,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
637,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
638,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
638,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
639,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
639,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
639,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
640,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
640,2,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
641,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
642,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
642,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
642,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
642,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
642,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
642,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
642,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
642,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
642,9,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
643,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
643,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
644,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
645,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
645,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
645,3,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
645,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
645,5,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
645,6,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
645,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
645,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
645,9,Smear cervix abnormal,Reproductive organ and breast histopathology procedures,Reproductive organ and breast investigations (excl hormone analyses),Inv,N
645,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
646,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
647,1,Breast cancer stage II,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
648,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
649,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
649,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
650,1,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
650,2,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
650,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
651,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
652,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
653,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
654,1,Administration site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
654,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
654,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
655,1,Nail growth abnormal,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
655,2,Onychoclasis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
655,3,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
656,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
656,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
656,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
656,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
656,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
656,6,Sinonasal obstruction,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
656,7,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
657,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
658,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
659,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
659,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
659,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
659,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
659,5,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
659,6,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
659,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
659,8,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
659,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
659,10,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
660,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
660,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
660,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
660,4,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
660,5,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
660,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
660,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
660,8,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
660,9,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
660,10,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
660,11,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
660,12,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
660,13,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
660,14,Headache,Headaches NEC,Headaches,Nerv,N
660,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
661,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
661,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
662,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
662,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
663,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
663,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
663,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
663,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
663,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
664,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
664,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
665,1,Atrophy,Trophic disorders,Tissue disorders NEC,Genrl,N
665,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
665,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
665,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
665,5,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
665,6,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
665,7,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
666,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
666,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
666,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
666,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
666,5,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
667,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
667,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
667,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
667,4,Immediate post-injection reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
668,1,Administration site odour,Administration site reactions NEC,Administration site reactions,Genrl,N
668,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
668,3,Injection site abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
668,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
668,5,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
668,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
668,7,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
668,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
669,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
669,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
669,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
670,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
670,2,Expanded disability status scale,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
670,3,Magnetic resonance imaging spinal abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
670,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
671,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
671,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
671,3,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
672,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
672,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
672,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
672,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
672,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
673,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
673,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
674,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
674,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
675,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
675,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
675,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
676,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
676,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
676,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
676,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
676,5,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
677,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
677,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
677,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
677,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
677,5,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
677,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
677,7,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
678,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
678,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
678,3,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
679,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
680,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
681,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
681,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
681,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
682,1,Anal pruritus,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
682,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
683,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
683,2,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
684,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
684,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
684,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
684,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
684,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
684,6,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
684,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
684,8,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
684,9,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
685,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
685,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
686,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
686,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
686,3,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
686,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
686,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
687,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
688,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
688,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
688,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
688,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
688,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
688,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
688,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,8,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
688,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
689,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
689,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
689,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
690,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
690,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
690,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
690,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
690,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
690,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
690,7,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
690,8,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
691,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
691,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
691,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
691,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
692,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
692,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
692,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
692,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
693,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
693,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
694,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
694,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
695,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
695,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
695,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
695,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
695,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
695,6,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
695,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
695,8,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
695,9,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
695,10,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
695,11,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
695,12,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
695,13,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
695,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
696,1,Headache,Headaches NEC,Headaches,Nerv,N
696,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
696,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
697,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
697,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
697,3,Salivary gland neoplasm,Salivary gland neoplasms unspecified malignancy,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
697,4,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
698,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
698,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
698,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
699,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
699,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
700,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
700,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
700,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
700,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
700,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
700,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
700,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
700,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
700,9,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
701,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,N
701,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
702,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
702,2,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
702,3,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
702,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
702,5,Eosinophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
702,6,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
702,7,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
702,8,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
702,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
702,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
702,11,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
702,12,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
702,13,Physical disability,Disability issues,Lifestyle issues,SocCi,N
702,14,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
702,15,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
702,16,Traumatic lung injury,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
703,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
703,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
703,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
703,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
703,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
704,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
704,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
705,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
706,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
707,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
707,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
707,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
707,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
708,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
708,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
709,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
710,1,Hydrosalpinx,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
711,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
711,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
711,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
711,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
712,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
712,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
712,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
712,4,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
713,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
713,2,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
713,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
714,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
715,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
715,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
715,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
715,4,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
715,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
716,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
716,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
716,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
717,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
717,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
717,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
717,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
717,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
717,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
718,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
718,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
719,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
719,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
719,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
719,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
720,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
721,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
721,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
721,3,Cardiac discomfort,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
721,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
721,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
721,6,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
721,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
722,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
722,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
722,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
722,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
722,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
722,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
722,7,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
723,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
723,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
724,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
724,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
725,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
725,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
726,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
726,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
727,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
728,1,Congenital musculoskeletal disorder of limbs,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
728,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
729,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
730,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
730,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
730,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
730,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
731,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
732,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
732,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
732,3,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
732,4,Wheelchair user,Disability issues,Lifestyle issues,SocCi,N
733,1,Headache,Headaches NEC,Headaches,Nerv,N
733,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
734,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
735,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
736,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
737,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
737,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
737,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
737,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
737,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
738,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
738,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
739,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
739,2,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
740,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
741,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
741,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
741,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
741,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
742,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
742,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
742,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
743,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
743,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
743,3,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
744,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
744,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
744,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
744,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
745,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
746,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
746,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
746,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
747,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
748,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
749,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
749,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
750,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
750,2,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
751,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
751,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
752,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
752,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
752,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
753,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
753,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
753,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
754,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
754,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
754,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
755,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
756,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
756,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
756,3,Muscle discomfort,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
756,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
757,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
758,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
758,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
758,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
758,4,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
758,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
759,1,Breast cancer female,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
760,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
760,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
760,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
760,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
760,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
761,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
762,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
762,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
763,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
763,2,Body mass index decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
763,3,Migraine,Migraine headaches,Headaches,Nerv,N
763,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
763,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
763,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
763,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
764,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
764,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
765,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
765,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
765,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
765,4,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
766,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
766,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
766,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
766,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
766,5,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
766,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
767,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
767,2,Tooth disorder,Dental disorders NEC,Dental and gingival conditions,Gastr,N
768,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
769,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
769,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
770,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
770,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
771,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
771,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
771,3,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
772,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
773,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
773,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
774,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
774,2,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
775,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
776,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
777,1,Migraine,Migraine headaches,Headaches,Nerv,N
778,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
779,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
780,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
780,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
780,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
781,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
781,2,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
781,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
782,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
782,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
782,3,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
782,4,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
782,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
782,6,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
782,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
782,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
782,9,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
782,10,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
782,11,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
782,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
782,13,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
783,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
783,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
784,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
784,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
785,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
785,2,Blood prolactin increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
785,3,Deafness,Hearing losses,Hearing disorders,Ear,N
786,1,Application site erosion,Application site reactions,Administration site reactions,Genrl,N
786,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
786,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
786,4,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
787,1,Injection site hypoaesthesia,Injection site reactions,Administration site reactions,Genrl,N
787,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
787,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
788,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
788,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
788,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
788,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
789,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,Y
789,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
790,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
790,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
790,3,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
791,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
791,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
792,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
793,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
793,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
794,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
794,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
794,3,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
794,4,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
794,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
795,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
795,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
795,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
796,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
796,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
796,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
797,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
797,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
798,1,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
799,1,Sinusitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
800,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
801,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
801,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
801,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
801,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
801,5,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
801,6,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
802,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
802,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
802,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
802,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
802,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
802,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
802,7,Migraine,Migraine headaches,Headaches,Nerv,N
802,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
802,9,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
803,1,Device issue,Device issues NEC,Device issues,Prod,N
803,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
804,1,Device issue,Device issues NEC,Device issues,Prod,N
804,2,Drug dose omission by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
804,3,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
805,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
805,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
805,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
805,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
805,5,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
805,6,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
805,7,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
805,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
805,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
805,10,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
805,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
806,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
806,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
806,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
807,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
808,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
808,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
808,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
809,1,Device connection issue,Device issues NEC,Device issues,Prod,N
809,2,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
809,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
809,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
809,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
809,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
809,7,Wrong dose,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
810,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
811,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
812,1,Device issue,Device issues NEC,Device issues,Prod,N
812,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
813,1,Device issue,Device issues NEC,Device issues,Prod,N
813,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
814,1,Device issue,Device issues NEC,Device issues,Prod,N
814,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
815,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
816,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
816,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
816,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
816,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
817,1,Device issue,Device issues NEC,Device issues,Prod,N
817,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
818,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
818,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
819,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
820,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
820,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
821,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
821,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
822,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
823,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
823,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
823,3,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
824,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
825,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
826,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
826,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
826,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
827,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
827,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
827,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
828,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
829,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
829,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
829,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
829,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
830,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
831,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
831,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
831,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
832,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
833,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
833,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
833,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
834,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
834,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
834,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
834,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
834,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
834,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
834,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
834,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
835,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
835,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
835,3,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
836,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
837,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
838,1,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
838,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
839,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
839,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
839,3,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
840,1,Endometriosis,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
841,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
842,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
842,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
843,1,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
843,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
843,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,2,Device issue,Device issues NEC,Device issues,Prod,N
844,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
845,1,Device leakage,Device issues NEC,Device issues,Prod,N
845,2,Device mechanical issue,Device physical property and chemical issues,Device issues,Prod,N
845,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
845,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
845,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
845,6,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
846,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
847,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
847,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
847,3,Choking,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
847,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
847,5,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
847,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
847,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
847,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
847,9,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
847,10,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
848,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
849,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
850,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
850,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
851,1,Acute leukaemia,Leukaemias acute NEC,Leukaemias,Neopl,N
852,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
853,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
854,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
855,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
856,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
856,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
856,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
857,1,Malignant melanoma stage II,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
857,2,Melanocytic naevus,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
858,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
858,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
858,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
859,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
859,2,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
859,3,Urine odour abnormal,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
860,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
860,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
861,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
862,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
862,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
862,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
862,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
862,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
862,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
863,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
864,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
865,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
865,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
865,3,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
866,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
866,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
867,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
868,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
868,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
868,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
868,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
869,1,Limb immobilisation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
869,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
870,1,Device issue,Device issues NEC,Device issues,Prod,N
870,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
871,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
871,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
871,3,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
871,4,Headache,Headaches NEC,Headaches,Nerv,N
871,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
871,6,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
871,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
871,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
872,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
873,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
873,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
874,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
875,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
876,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
876,2,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
877,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,1,Device issue,Device issues NEC,Device issues,Prod,N
878,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
879,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
879,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
879,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
879,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
880,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
881,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
881,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
882,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
882,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
882,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
882,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
882,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
882,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
882,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
882,8,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
882,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
883,1,Craniotomy,Skull and brain therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
884,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
884,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
884,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
885,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
886,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
886,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
886,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
886,4,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
886,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
886,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
886,7,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
887,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
887,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
887,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
887,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
887,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
887,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
887,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
887,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
887,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
888,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
889,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
890,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
891,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
891,2,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
892,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
893,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
893,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
894,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
894,2,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
895,1,Device use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
895,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
895,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
895,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
896,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
897,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
897,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
897,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
898,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
898,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
899,1,Device information output issue,Device information output issues,Device issues,Prod,N
899,2,Device issue,Device issues NEC,Device issues,Prod,N
899,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
899,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
900,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
901,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
902,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
903,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
903,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
904,1,Developmental delay,General signs and symptoms NEC,General system disorders NEC,Genrl,N
904,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
904,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
905,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
905,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
906,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
907,1,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
908,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
908,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
909,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
909,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
910,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
910,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
911,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
911,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
911,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
911,4,Product delivery mechanism issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
912,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
913,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
914,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
915,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
916,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
917,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
917,2,Wound decomposition,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
918,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
918,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
918,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
919,1,Device issue,Device issues NEC,Device issues,Prod,N
919,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
919,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
920,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
920,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
920,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
920,4,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
920,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
921,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
921,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
922,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
922,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
923,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
923,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
923,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
923,4,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
923,5,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
924,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
925,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
926,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
926,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
926,4,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
926,5,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
926,6,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
926,7,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
926,8,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
926,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
927,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
928,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
928,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
928,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
928,4,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
928,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
929,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
930,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
930,2,Metastases to central nervous system,Metastases to specified sites,Metastases,Neopl,N
931,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
932,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
932,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
932,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
932,4,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
932,5,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
932,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
933,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
933,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
933,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
934,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
934,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
934,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
934,4,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
934,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
935,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
936,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
936,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
936,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
936,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
937,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
937,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
938,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
938,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
939,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
940,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
941,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
941,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
942,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
942,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
942,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
942,4,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
942,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
942,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
942,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
943,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
944,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
944,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
945,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
946,1,Device issue,Device issues NEC,Device issues,Prod,N
946,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
947,1,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
948,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
948,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
948,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
949,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
950,1,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
951,1,Adverse event following immunisation,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
951,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
952,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
953,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
954,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
955,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
955,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
956,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
957,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
958,1,Device physical property issue,Device physical property and chemical issues,Device issues,Prod,N
959,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
960,1,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
961,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
961,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
962,1,Skin wound,Skin injuries NEC,Injuries NEC,Inj&P,N
963,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
963,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
964,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
964,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
965,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
965,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
966,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
967,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
968,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
969,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
970,1,Lymphoedema,Lymphoedemas,Lymphatic vessel disorders,Vasc,N
971,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
971,2,Injection site paraesthesia,Injection site reactions,Administration site reactions,Genrl,N
972,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
973,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
973,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
973,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
974,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
